Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Short Description

I work part time as a GP at the Windrush Medical Practice in Witney, West Oxfordshire.

My current areas of research interest are acute respiratory tract infections, postinfectious cough and management of respiratory complaints at the primary/secondary care interface. 

I am a tutor on the mixed methods research module of the MSc in Evidence Based Health Care.  I also have experience of teaching at both undergraduate and postgraduate level on critical appraisal of randomised controlled trials and diagnostic test accuracy studies.

DPHIL SUPERVISION 

Oliver van Hecke - Behaviours and consequences associated with antibiotic prescribing and antibiotic resistance in primary care

Kay Wang

MA (Cantab) BM BCh (Oxon) DRCOG DFSRH DCH MRCGP DPhil

Academic Clinical Lecturer

Biography

I am the Oxford Programme Lead of the ARCHIE programme (early Antibiotic use in 'at Risk' CHildren with InfluEnza), which is funded by an NIHR Programme Grant for Applied Research.  'At risk' children with underlying conditions such as asthma, diabetes, cerebral palsy are more prone than otherwise healthy children to becoming more unwell from influenza-related complications such as chest, ear and throat infections.  The ARCHIE programme will develop a robust evidence base for treating these children with antibiotics early during an influenza-like illness. These findings will play a key role in informing antibiotic prescribing policy during influenza epidemics and pandemics. 

Persistent 'postinfectious' cough following an acute respiratory tract infection is also a commonly encountered problem in primary care.  I have led the delivery of two key studies in this area.  Firstly, a multi-centre clinical trial to find out whether montelukast, a medication which is already used to treat asthma, is also an effective treatment for postinfectious cough, and secondly, a study to work out how commonly we find whooping cough (pertussis) and Mycoplasma pneumoniae infections in children with postinfectious cough.  These findings will help inform evidence-based management of postinfectious cough as well as inform whooping cough immunisation policy in the UK.